Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.

Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM.

Blood Adv. 2019 Jul 9;3(13):1961-1969. doi: 10.1182/bloodadvances.2019030924.

2.

Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.

Haber P, Moro PL, Ng C, Dores GM, Lewis P, Cano M.

Vaccine. 2019 Mar 7;37(11):1516-1520. doi: 10.1016/j.vaccine.2019.01.052. Epub 2019 Feb 7.

PMID:
30739795
3.

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.

Morton LM, Dores GM, Schonfeld SJ, Linet MS, Sigel BS, Lam CJK, Tucker MA, Curtis RE.

JAMA Oncol. 2018 Dec 20. doi: 10.1001/jamaoncol.2018.5625. [Epub ahead of print]

PMID:
30570657
4.

Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.

Linet MS, Gilbert ES, Vermeulen R, Dores GM, Yin SN, Portengen L, Hayes RB, Ji BT, Lan Q, Li GL, Rothman N; Chinese Center for Disease Control and Prevention–US National Cancer Institute Benzene Study Group .

J Natl Cancer Inst. 2019 May 1;111(5):465-474. doi: 10.1093/jnci/djy143.

PMID:
30520970
5.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.

Leukemia. 2018 Dec;32(12):2580-2589. doi: 10.1038/s41375-018-0149-2. Epub 2018 May 24.

PMID:
29795414
6.

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.

Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM.

J Natl Cancer Inst. 2018 Nov 1;110(11):1248-1258. doi: 10.1093/jnci/djy052.

7.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

8.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

9.

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM.

Br J Haematol. 2016 Aug;174(3):382-96. doi: 10.1111/bjh.14061. Epub 2016 Apr 7. Erratum in: Br J Haematol. 2017 Apr;177(2):331.

10.

Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.

Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM.

Leukemia. 2016 May;30(5):1187-90. doi: 10.1038/leu.2015.248. Epub 2015 Sep 15. No abstract available.

11.

Retrospective benzene exposure assessment for a multi-center case-cohort study of benzene-exposed workers in China.

Portengen L, Linet MS, Li GL, Lan Q, Dores GM, Ji BT, Hayes RB, Yin SN, Rothman N, Vermeulen R; Chinese Center for Disease Control and Prevention—U.S. National Cancer Institute Benzene Study Group.

J Expo Sci Environ Epidemiol. 2016 May-Jun;26(3):334-40. doi: 10.1038/jes.2015.44. Epub 2015 Aug 12.

PMID:
26264985
12.

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF Jr, Tucker MA, Morton LM.

J Clin Oncol. 2015 Oct 1;33(28):3096-104. doi: 10.1200/JCO.2014.60.2094. Epub 2015 Aug 3.

13.

A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers.

Linet MS, Yin SN, Gilbert ES, Dores GM, Hayes RB, Vermeulen R, Tian HY, Lan Q, Portengen L, Ji BT, Li GL, Rothman N; Chinese Center for Disease Control and Prevention-U.S. National Cancer Institute Benzene Study Group.

Int J Cancer. 2015 Nov 1;137(9):2184-97. doi: 10.1002/ijc.29591. Epub 2015 Jun 16.

14.

A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010.

Dores GM, Qubaiah O, Mody A, Ghabach B, Devesa SS.

BMC Cancer. 2015 Mar 27;15:185. doi: 10.1186/s12885-015-1188-y.

15.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

16.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

17.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

18.

Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM.

Br J Haematol. 2014 Apr;165(1):67-77. doi: 10.1111/bjh.12730. Epub 2014 Jan 12.

19.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

20.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.

21.

Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.

Kurdgelashvili G, Dores GM, Srour SA, Chaturvedi AK, Huycke MM, Devesa SS.

Cancer. 2013 Jun 15;119(12):2291-9. doi: 10.1002/cncr.27989. Epub 2013 Apr 11.

22.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF Jr, Curtis RE.

Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.

23.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

24.

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM.

Blood. 2012 Jan 5;119(1):34-43. doi: 10.1182/blood-2011-04-347872. Epub 2011 Nov 15.

25.

Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans.

Landgren AM, Landgren O, Gridley G, Dores GM, Linet MS, Morton LM.

Cancer. 2011 Mar 15;117(6):1163-71. doi: 10.1002/cncr.25524. Epub 2010 Nov 2.

26.

Melanoma of the skin and laterality.

Dores GM, Huycke MM, Devesa SS.

J Am Acad Dermatol. 2011 Jan;64(1):193-5; author reply 195-6. doi: 10.1016/j.jaad.2010.06.062. No abstract available.

27.

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.

Dores GM, Anderson WF, Beane Freeman LE, Fraumeni JF Jr, Curtis RE.

Br J Cancer. 2010 Sep 28;103(7):1081-4. doi: 10.1038/sj.bjc.6605877. Epub 2010 Sep 14.

28.

Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.

Ghabach B, Anderson WF, Curtis RE, Huycke MM, Lavigne JA, Dores GM.

Breast Cancer Res. 2010;12(4):R54. doi: 10.1186/bcr2613. Epub 2010 Jul 23.

29.

Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006.

Qubaiah O, Devesa SS, Platz CE, Huycke MM, Dores GM.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1908-18. doi: 10.1158/1055-9965.EPI-10-0328. Epub 2010 Jul 20.

30.

Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

Dores GM, Huycke MM, Devesa SS, Garcia CA.

J Am Acad Dermatol. 2010 Jul;63(1):71-8. doi: 10.1016/j.jaad.2009.07.027. Epub 2010 May 5.

31.

Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.

Boukheris H, Curtis RE, Land CE, Dores GM.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2899-906. doi: 10.1158/1055-9965.EPI-09-0638. Epub 2009 Oct 27.

32.

Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA.

AIDS. 2009 Jan 28;23(3):385-93. doi: 10.1097/QAD.0b013e3283213046.

33.

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.

Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS.

Br J Haematol. 2009 Jan;144(1):86-94. doi: 10.1111/j.1365-2141.2008.07421.x. Epub 2008 Nov 11.

34.

Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Dores GM, Curtis RE, Toro JR, Devesa SS, Fraumeni JF Jr.

Cancer. 2008 Dec 15;113(12):3372-81. doi: 10.1002/cncr.23963.

35.

Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis.

Boukheris H, Ron E, Dores GM, Stovall M, Smith SA, Curtis RE.

Cancer. 2008 Dec 1;113(11):3153-9. doi: 10.1002/cncr.23918.

36.

Hairy cell leukaemia: a heterogeneous disease?

Dores GM, Matsuno RK, Weisenburger DD, Rosenberg PS, Anderson WF.

Br J Haematol. 2008 Jul;142(1):45-51. doi: 10.1111/j.1365-2141.2008.07156.x. Epub 2008 May 8.

37.

Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States.

Dores GM, Curtis RE, Anderson WF, Demierre MF.

Arch Dermatol. 2008 Mar;144(3):413-4. doi: 10.1001/archderm.144.3.413. No abstract available.

PMID:
18347305
38.

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.

Linet MS, Schubauer-Berigan MK, Weisenburger DD, Richardson DB, Landgren O, Blair A, Silver S, Field RW, Caldwell G, Hatch M, Dores GM.

Br J Haematol. 2007 Dec;139(5):672-86. Review.

PMID:
18021081
39.

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.

Worrillow LJ, Smith AG, Scott K, Andersson M, Ashcroft AJ, Dores GM, Glimelius B, Holowaty E, Jackson GH, Jones GL, Lynch CF, Morgan G, Pukkala E, Scott D, Storm HH, Taylor PR, Vyberg M, Willett E, Travis LB, Allan JM.

J Med Genet. 2008 Mar;45(3):142-6. Epub 2007 Oct 24.

40.

Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.

Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, Rabkin CS, Devesa SS, Linet MS.

Br J Haematol. 2007 Dec;139(5):809-19. Epub 2007 Oct 17.

PMID:
17941952
41.

Noncancer causes of death in survivors of testicular cancer.

Fosså SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB.

J Natl Cancer Inst. 2007 Apr 4;99(7):533-44.

PMID:
17405998
42.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB.

J Clin Oncol. 2007 Apr 20;25(12):1489-97. Epub 2007 Mar 19.

PMID:
17372278
43.

Comparison of age distribution patterns for different histopathologic types of breast carcinoma.

Anderson WF, Pfeiffer RM, Dores GM, Sherman ME.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1899-905.

44.

Merkel cell carcinoma and multiple primary cancers.

Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1545-9.

45.

Evaluating research training outcomes: experience from the cancer prevention fellowship program at the National Cancer Institute.

Dores GM, Chang S, Berger VW, Perkins SN, Hursting SD, Weed DL.

Acad Med. 2006 Jun;81(6):535-41.

PMID:
16728801
47.

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.

Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, Storm H, Andersen A, Pukkala E, Holowaty E, Kaijser M, Andersson M, Joensuu H, Fosså SD, Allan JM, Travis LB.

J Natl Cancer Inst. 2006 Feb 1;98(3):215-8.

PMID:
16449681
48.

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD Jr, Gilbert E, Gail MH.

J Natl Cancer Inst. 2005 Oct 5;97(19):1428-37.

PMID:
16204692
50.

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES.

J Natl Cancer Inst. 2005 Sep 21;97(18):1354-65.

PMID:
16174857

Supplemental Content

Loading ...
Support Center